Therapeutic Evaluation of Anti-Angiogenic and Chemotherapy with or
without Cox-2 Inhibitor and Immunomodulator Drug in the Management
of Canine Mammary Neoplasm
Kodakkadan
Manikkan Dileepkumar, Swapan Kumar Maiti*, Naveen Kumar and Malik
Mohammad Shams-uz-Zama
Division of Surgery, Indian Veterinary Research
Institute, Izatnagar 243 122, (UP), India *Corresponding author: maiti_62@rediffmail.com; swapanivri@gmail.com
Abstract
The present study was
conducted for exploring the activity of anti-angiogenic and chemotherapeutic
treatment with or without cox-2 inhibitor and immunomodulator drug in the
management of spontaneous canine mammary neoplasms. Anti-angiogenic drug (Tamoxifen)
(n=10), chemotherapy (5-FU) (n=10), chemotherapy (5-FU) along with cox-2
inhibitor (Etoricoxib) (n=10), chemotherapy (5-FU) along with cox-2 inhibitor (Etoricoxib)
and immunomodulator drug (Levamisole) (n=10) were used in 40 female dogs having
spontaneous mammary neoplasms. Anticancer drug (5-FU) and anti-angiogenic drug (Tamoxifen) induced
apoptosis in canine mammary neoplasms. Immunomodulator drug (Levamisole) along
with cox-2 inhibitor (Etoricoxib) and chemotherapeutic drug (5–fluorouracil)
induced significantly (P<0.01) higher apoptosis. In conclusion, chemotherapy
with immunomodulator drug and cox-2 inhibitor was clinically proved better than
chemotherapeutic agent (5-FU) alone in the treatment of canine mammary neoplasms.